QUANTITATIVE CONTRAST-ENHANCED ULTRASOUND BY SONAZOID IN THE EARLY DIAGNOSIS OF BILIARY ATRESIA: AN EXPERIMENTAL STUDY OF RATS WITH BILE DUCT LIGATION

Yangdi Wang,Xiaoyan Xie,Qinghua Cao,Wenxuan Xie,Dong Chen,Xiaoer Zhang,Yu Guo,Luyao Zhou
DOI: https://doi.org/10.1016/j.ultrasmedbio.2019.06.409
IF: 3.694
2019-01-01
Ultrasound in Medicine & Biology
Abstract:We aimed to investigate the feasibility of quantitative Sonazoid contrast-enhanced ultrasound (CEUS) in the diagnosis of biliary atresia (BA) at an early disease stage. First, liver tissue from 10 patients with BA and 10 patients with infantile hepatitis syndrome (IHS) was immunostained with cluster of differentiation 68 (CD68) to compare Kupffer cell counts. Then, quantitative Sonazoid CEUS was performed to evaluate the hyperplasia of the artery branches during the artery phase and changes in Kupffer cell counts during the Kupffer phase in a rat model of BA (common bile duct ligation). Based on our results, liver enhancement from Kupffer cells in BA patients was significantly higher than that in IHS patients (p = 0.026 < 0.05). Furthermore, quantitative CEUS showed that the liver enhancement intensity of rats with bile duct ligation was substantially greater than that of rats without bile duct ligation during the artery phase 3 d post-operation and the Kupffer phase 5 d post-operation. The increased enhancement intensity in the Kupffer phase was in agreement with the increase in Kupffer cell counts in pathologic staining (18/20, 90%). In conclusion, quantitative Sonazoid CEUS can detect the hyperplasia of artery branches in artery phase and the increase of Kupffer cells in Kupffer phase in the liver of BA rats at an early disease stage. Therefore, Sonazoid CEUS could potentially be a valuable non-invasive alternative for the diagnosis of BA.
What problem does this paper attempt to address?